Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $44.81 ($1.8M) on 2019-08-21, disclosed to the SEC on 2019-08-23.
Seasonal sale ($1.8M) by Chief Executive Officer — this insider has traded FGEN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.79 | 18,400 | $824K | 46.9% |
| 2 | $44.81 | 1,418 | $64K | 3.6% |
| 3 | $43.77 | 1,418 | $62K | 3.5% |
| 4 | $43.80 | 17,100 | $749K | 42.6% |
| 5 | $44.73 | 1,300 | $58K | 3.3% |
| Total | $44.33 avg | 39,636 |
| $1.8M |
| 100% |
| Filing → |
| FGEN | SELL | 2018-12-06 | $1.2M | — | Filing → |
| FGEN | SELL | 2018-11-21 | $1.5M | — | Filing → |
| FGEN | SELL | 2018-11-02 | $1.6M | — | Filing → |